Do not ignore the impact of pharmaceutical rates, says an analyst. Where we stop in Bristol Myers

Cramer says it's better to come to Oracle, also look at BIRK, JNJ, PARA, CASY

Higs & Herh Sarias immerse 28% in concerns about the weight loss business, margins

CEO from UnitedHealth Group Andrew Witty Step Down

Novo Nordisk Reaches $500 Billion in Market Value as It Points to Growing Demand for Wegovy and Ozempic

Humira sales fall, but AbbVie has successors

Pfizer's gene therapy for hemophilia A successfully passes late-stage trials